The FDA has issued a partial clinical hold pausing new patient enrollment in Mersana Therapeutics Inc's (NASDAQ: MRSN) UP-NEXT and UPGRADE-A, the company's ongoing clinical trials of UpRi in
– Undertakes Transformational Opportunity in Partnership with Industry Leading Beverage Solutions Company and Largest Co-Packer in the U.S. –Nashville, TN, Oct. 05, 2023 (GLOBE NEWSWIRE) -- American Rebel Holdings, Inc.